Login / Signup

Hyperprogressive disease in leiomyosarcoma: a threat to the use of single-agent anti-PD-(L)1 therapy?

Tarek AssiOlivier Mir
Published in: Immunotherapy (2022)
Keyphrases
  • stem cells
  • replacement therapy
  • smoking cessation